DynPort Vaccine

vaccine therapeutics for biodefense purposes

History:

DynPort Vaccine was formed as a joint venture between Computer Sciences Corporation and Porton International. In 2004 CSC bought out Porton's interest in the venture.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Northeast

Research Focus:
Disease Therapeutics:Clinical late (III) Therapeutics-Marketing

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: